May 26, 2020 00:55
4 yrs ago
9 viewers *
English term
disease-modifying anti-rheumatic drug (DMARD)
COVID-19
GBK
English to Dutch
Medical
Medical (general)
Definition from
National Center for Biotechnology Info.:
Disease-modifying antirheumatic drugs (DMARDs) are a class of drugs indicated for the treatment of inflammatory arthritides including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). They can also be used to in the treatment of other disorders including connective tissue disease such as systemic sclerosis (SSc), systemic lupus erythematosus (SLE), and Sjogren syndrome (SS), as well as in treatment of inflammatory myositis, vasculitis, uveitis, inflammatory bowel disease, and some types of cancers.
Example sentences:
Hydroxychloroquine has been available since 1955 as an antimalarial drug. I have at least 6 patients at the pharmacy who have used hydroxychloroquine to manage their rheumatoid arthritis, lupus, and Crohn disease. If you were sitting in my pharmacology class, I’d tell you that it is an antimalarial used as a disease-modifying antirheumatic drug (DMARD). I would tell you it is a cheap drug with good efficacy for some and also that it is 1 of 2 DMARDs that are safe to use in patients with liver failure. You would also learn that it may cause deposition of the drug in the melanin layer of the cones in the retina, underscoring the need for annual eye exams. (MJH Life Sciences)
DMARDs Not Linked to Poor Outcomes in SARS-CoV-2 RA Patients (Rheumatology Network)
The analysis of performance measures for rheumatoid arthritis (RA) care have allowed to identify gaps in care that include suboptimal use of disease-modifying anti-rheumatic drugs (DMARDs), according to a study published in Arthritis Care & Research. (Rheumatology Advisor)
Proposed translations
(Dutch)
| 4 +2 | Ziekteverloop beïnvloedende geneesmiddelen tegen reuma |
Stieneke Hulshof
|
Change log
May 23, 2020 00:29: changed "Kudoz queue" from "In queue" to "Public"
May 26, 2020 00:55: changed "Stage" from "Preparation" to "Submission"
May 29, 2020 01:57: changed "Stage" from "Submission" to "Completion"
Proposed translations
+2
8 hrs
Stieneke Hulshof
Spain
Spain
Spain
Sworn: Business Legal Healthcare Tourism
Native in: Dutch (Variants: Netherlands, Flemish) 
Works in: English to Dutch, Spanish to Dutch, Dutch, and 1 more.
Related KudoZ points
:
12
Selected
Ziekteverloop beïnvloedende geneesmiddelen tegen reuma
Definition from
nl.wikipedia.org:
Disease-modifying antirheumatic drugs ("ziekteverloop beïnvloedende geneesmiddelen tegen reuma") of DMARD's vormen een groep geneesmiddelen die de activiteit van ontstekingen in de gewrichten vermindert. De middelen worden gegeven met als doelstelling het zo veel mogelijk voorkomen van gewrichtsbeschadiging zoals die bij reumatoïde artritis veel voorkomen.
Example sentences:
Sulfasalazine is een middel dat ontstekingen in de gewrichten onderdrukt bij een aantal vormen van reuma. Het is sinds 1944 op de markt. Dit medicijn behoort tot de zogenaamde DMARDs. Deze letters staan voor Disease-Modifying AntiRheumatic Drugs wat ‘ziekteverloop beïnvloedende geneesmiddelen tegen reuma’ betekent. (Bewegenzonderpijn.com)
Artsen schrijven vaak medicijnen voor bij artritis om de symptomen en de voortschrijding van de ziekte in bedwang te houden. Er zijn verschillende categorieën van medicatie bij artritis: NSAIDs (niet-steroïde anti-inflammatoire drugs), analgetica (pijnstillers), DMARDs (ziekteverloop beïnvloedende geneesmiddelen tegen reuma), biologische middelen, en corticosteroïden. (Artroseblog.nl)
psoriatische artritis (ontsteking van de gewrichten die geassocieerd wordt met psoriasis) wanneer ziekteverloop beïnvloedende geneesmiddelen tegen reuma (‘disease-modifying anti-rheumatic drugs’ – DMARD’s) niet goed genoeg werken; (Ema.Europa.eu)
4 KudoZ points awarded for this answer.
Something went wrong...